Is it time to re-design the haematuria clinic?

BJU International

Volumn 105, Issue 5, 2010, Pages 585-588

  Mostafid, Hugh ^a   Persad, Raj ^b   Kockelbergh, Roger ^c   Fawcett, Derek ^d  

^a NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c LEICESTER GENERAL HOSPITAL   (United Kingdom)

^d ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BLADDER CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CARCINOMA IN SITU; CYSTOSCOPY; DIAGNOSTIC IMAGING; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HEMATURIA; HUMAN; KIDNEY DISEASE; NOTE; OUTPATIENT DEPARTMENT; PRIMARY TUMOR; PRIORITY JOURNAL; URINE CYTOLOGY;

CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; HEMATURIA; HUMANS; REFERRAL AND CONSULTATION; URINARY BLADDER NEOPLASMS;

EID: 77149177963     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.09108.x     Document Type: Note

References (16)

1. Mariani A, Mariani A, Macchioni C, Stams U, Hariharan A, Moriera A. The significance of adult haematuria: 1000 haematuria evaluations including risk-benefit and cost-effectivness analysis. J Urol 1989 141 : 350 355
2. Edwards TJ, Dickinson AJ, Natale S, Gosling J, McGrath JS. A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol-driven haematuria clinic. BJU Int 2006 97 : 301 305
3. Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1930 patients with hematuria to evaluate current diagnostic practice. J Urol 2000 163 : 524 527
4. Whelan P, Taylor M, Wright D. Economic burden of bladder cancer in the UK. BJU Int 2008 101 (Suppl. 5 35
5. Kelly JD, Fawcett DP, Goldberg LC. Assessment and management of non-visible haematuria in primary care. BMJ 2009 338 : a3021
6. Viswanath S, Zlehof B, Ho E, Sethia K, Mills R. Is routine urine cytology useful in the haematuria clinic. Ann R Coll Surg Engl 2008 90 : 153 155
7. Rooke G, Gupta S, Potter J, Miller M, Bell R, Kunkler R. The role of urine cytology in the initial assessment of patients with haematuria. BJU Int 2007 99 (Suppl. 4 22
8. Barrass B, Astall E, Sharma S, Blackford H. Urine cytology in the investigation of haematuria - is it really worth it? BJU Int 2007 99 (Suppl. 4 22
9. Bott S, Chanawani M, Mostafid H. The use of the NMP22 BladderChek test for bladder cancer to optimise investigations in a one-stop haematuria clinic. BJMSU 2008 1 : 126 130
10. Turner B, Grey A, Balthun S, Pati J. Sensitivity and specificity of NMP22 in detecting urothelial cancer in haematuria patients. Eur Urol 2009 8 (Suppl. 4 226
11. Grossman HB, Messing E, Soloway M et al. Detection of bladder cancer using a point-of-care proteomic assay. JAMA 2005 293 : 810 816
12. Talwar R, Sinha T, Karan S et al. Voided urinary cytology in bladder cancer: is it time to review the indications. Urology 2007 70 : 267 271
13. Wang L, Wong Y, Chuang C, Hunag C, Pang S. Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography in patients with gross haematuria. J Urol 2009 181 : 524 531
14. Grossman H, Gomella L, Fradet Y et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007 178 : 62 7
15. Van der Aa M, Steyerberg E, Bangma C, Van Rhijn Zwarthoff E, Van Der Kwast TH. Cystoscopy revisited as the gold standard for detection of bladder cancer recurrences: diagnostic review bias in a prospective randomized trial. Eur Urol 2009 8 (Suppl. 4 374
16. Rodgers M, Nixon J, Hempel S et al. Diagnostic tests and algorithms used in the investigation of haematuria: systemic reviews and economic evaluation. Health Technol Assess 2006 10 : iii iv, xi 259